American Well Co. (NYSE:AMWL – Get Rating) reached a new 52-week low during trading on Friday . The company traded as low as $2.28 and last traded at $2.31, with a volume of 2013269 shares trading hands. The stock had previously closed at $2.50.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on AMWL. Piper Sandler downgraded American Well from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $5.00 to $3.50 in a report on Monday, February 27th. Cowen lowered their price target on American Well from $9.00 to $5.00 in a report on Monday, February 27th. Credit Suisse Group lowered their price target on American Well from $5.00 to $4.00 and set a “neutral” rating for the company in a report on Thursday, February 23rd. Morgan Stanley lowered their price target on American Well from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Monday, March 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of American Well in a report on Thursday, February 23rd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.53.
American Well Price Performance
The business’s 50-day simple moving average is $3.41 and its two-hundred day simple moving average is $3.58.
Insiders Place Their Bets
In other American Well news, CFO Robert Shepardson sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, March 10th. The shares were sold at an average price of $2.36, for a total value of $47,200.00. Following the sale, the chief financial officer now owns 1,091,225 shares in the company, valued at $2,575,291. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other American Well news, COO Kurt Knight sold 25,680 shares of American Well stock in a transaction on Monday, March 6th. The shares were sold at an average price of $2.73, for a total transaction of $70,106.40. Following the completion of the sale, the chief operating officer now owns 1,381,401 shares of the company’s stock, valued at approximately $3,771,224.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert Shepardson sold 20,000 shares of American Well stock in a transaction on Friday, March 10th. The shares were sold at an average price of $2.36, for a total transaction of $47,200.00. Following the sale, the chief financial officer now directly owns 1,091,225 shares of the company’s stock, valued at approximately $2,575,291. The disclosure for this sale can be found here. Insiders have sold 211,298 shares of company stock valued at $676,446 over the last quarter. Insiders own 13.91% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Point72 Middle East FZE bought a new position in shares of American Well during the 4th quarter worth about $33,000. Point72 Hong Kong Ltd boosted its holdings in American Well by 175.1% during the first quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company’s stock worth $34,000 after purchasing an additional 5,147 shares during the last quarter. MQS Management LLC acquired a new position in American Well during the fourth quarter worth $40,000. Mackenzie Financial Corp acquired a new position in American Well during the first quarter worth $43,000. Finally, Corient Capital Partners LLC acquired a new stake in American Well in the second quarter valued at $46,000. Institutional investors own 46.30% of the company’s stock.
American Well Company Profile
American Well Corporation operates digital care delivery enablement platform in the United States and internationally. Its platform connects and enables providers, insurers, patients, and innovators to deliver access to care. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings.
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.